Clinical Trial Update: Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating chidamide in combination with CHOPE for peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Peking University | Conditions: Experimental Tumor | Phase 2 | Status: UNKNOWN